[15] The annual report filed by Hims & Hers describes the companys compounded injectable semaglutide drugs that are part of the companys weight loss specialty: In May 2024, we began offering access to GLP-1s, first in the form of compounded injectable semaglutide and in August 2024, in the form of branded (or FDA-approved) injectable semaglutide, as part of our weight loss specialty
Cross-trial comparison is inherently limited
Phase 2 trial data showed meaningful body weight reduction and improvements in HbA1c, triglycerides, and waist circumference across treatment groups
A patent thicket is a dense web of secondary patents that brand-name drug manufacturers create around a blockbuster drug, covering not just the core molecule but also its formulation, method of use, and manufacturing process
MPs/NPs are either directly used in cosmetics, detergents, lotions, shampoos, synthetic textiles, and industrial processes, or formed secondarily through the degradation of larger plastic items such as packaging or tire (Zheng et al., 2024)
Copays for weight loss treatment visits with Anthem Blue Cross Blue Shield in Virginia vary based on your specific plan, whether you have met your deductible, and whether your provider is in-network
